Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A1EWVY8
Tue, 17.11.2026       Formycon AG

Press Release // November 17, 2026   Two Blockbusters, Two Niche-Busters, One Smart Portfolio: Formycon Names Tezspire® and Hemlibra® as Reference Drugs   FYB210: biosimilar candidate to tezepelumab (Tezspire®); sales of the reference drug rose by 50 percent to USD 1.9 billion in 2025 FYB286: biosimilar candidate to emicizumab (Hemlibra®); no  [ … ]
Thu, 12.11.2026       Formycon AG

Press Release // November 12, 2026   Formycon Doubles Nine-Month Revenue and Consistently Advances Implementation of its FYB4Growth Strategy   Consolidated revenue rises to €40.0 million in the first nine months of 2026 (prior-year period: € 19.5 million) EBITDA and adjusted EBITDA improved significantly year-on-year to €-8.9 million (prior-yea [ … ]
Thu, 05.11.2026       Formycon AG

Press Release // November 05, 2026   Formycon maintains 2026 guidance for revenue, EBITDA and working capital, revises adjusted EBITDA and reassesses FYB201 and FYB202   2026 guidance: revenue of EUR 60 to 70 million, EBITDA of EUR 0 to 10 million and working capital of EUR 20 to 30 million unchanged, revenue and EBITDA each at the lower end of [ … ]
Tue, 03.11.2026       Formycon AG

Company Name: Formycon AG ISIN: DE000A1EWVY8   Reason for the research: Update Recommendation: Buy from: 03.11.2026 Target price: €50 Target price on sight of: 12 months Last rating change: - Analyst: Simon Scholes First Berlin Equity Research has published a research update on Formycon AG (ISIN: DE000A1EWVY8). Analyst Simo [ … ]
Tue, 06.10.2026       Formycon AG

  Press Release // October 6, 2026   Formycon Optimizes Biosimilar Development with AI-Powered Technologies: Digital Solutions Enhance Development Efficiency as Part of the FYB4GROWTH Strategy Targeted use of digital technologies, including artificial intelligence, supports the lean development approach of Formycon and strengthens efficiency an [ … ]
Wed, 12.08.2026       Formycon AG

Press Release // August 12, 2026   Formycon reports key operational achievements in the first half of 2026 and significantly improves financial results year-on-year First-half financial results significantly improved year-on-year, with a substantial increase in revenue – 2026 guidance confirmed Successful completion of FYB206 clinical developmen [ … ]
Wed, 05.08.2026       Formycon AG

Press Release // August 5, 2026 Formycon invites to conference call on 2026 half-year results and announces participation in international investor conferences Planegg-Martinsried, Germany – Formycon AG (FSB: FYB, Prime Standard, „Formycon“) plans to publish its results for the first half of the 2026 fiscal year on August 12, 2026. The Management [ … ]
Tue, 14.07.2026       Formycon AG

Press Release // July 14, 2026   Formycon AG and OneSource Specialty Pharma announce strategic Manufacturing Partnership for Biosimilars   Munich, Germany / Bangalore, India, July 14, 2026 – Formycon AG (FSE: FYB, Prime Standard, “Formycon”) and OneSource Specialty Pharma Limited (BSE: 544292, NSE: ONESOURCE, “OneSource”), a multi-modality specia [ … ]
Mon, 22.06.2026       Formycon AG

Company Name: Formycon AG ISIN: DE000A1EWVY8   Reason for the research: Update Recommendation: Buy from: 22.06.2026 Target price: €50 Target price on sight of: 12 months Last rating change: - Analyst: Simon Scholes First Berlin Equity Research has published a research update on Formycon AG (ISIN: DE000A1EWVY8). Analyst Simo [ … ]
Wed, 10.06.2026       Formycon AG

Press Release // June 10, 2026   Formycon AG Reports Results of Annual General Meeting 2026   Management Board provides detailed review of fiscal year 2025 and outlook for 2026 Shareholders approve all agenda items by large majorities and formally approve the actions of the Management and Supervisory Boards   Planegg-Martinsried – Formycon AG ( [ … ]

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

© 2026 Select Sector SPDRs

* * *

More Sector related Investment Ideas
© 2026 WEBs Investments ETFs
Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Thursday, 19.11.2026, Calendar Week 47, 323rd day of the year, 42 days remaining until EoY.